News
AstraZeneca's gefurulimab showed clinical benefits and favorable safety in Phase 3 trial for adults with anti-AChR ...
Los Angeles Capital Management LLC dramatically increased its Johnson & Johnson holdings by 213.6% in Q1, now owning ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Johnson & Johnson reported strong second-quarter growth in its Jacksonville-based vision products business and expects more ...
20h
Barchart on MSN2 Recession-Proof Dividend Stocks to Buy for the Second Half of 2025With economic uncertainty looming in the second half of 2025, as well as lingering inflationary pressures and potential interest rate changes, investors are becoming more cautious about where to ...
One key theme that runs through the two examples here is consistency. On that score, Johnson & Johnson has the best track ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...
Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.
In a bold move, Allegiance Financial Group Advisory Services LLC has significantly increased its investment in Johnson & Johnson, purchasing an additional 3,076 shares, boosting their holdings by a ...
Johnson & Johnson shares fell slightly Thursday after soaring yesterday amid investor optimism about the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results